commit | 761ea581289d10ff134fb91a8e5733d796003ea2 | [log] [tgz] |
---|---|---|
author | Bazel Release System <noreply@google.com> | Fri Jul 12 22:45:54 2024 +0200 |
committer | Florian Weikert <fwe@google.com> | Fri Jul 12 22:45:54 2024 +0200 |
tree | 7bfdecb09ac604cafa0859887c8773accc296d41 | |
parent | 3f93d377d036d773fd505a18e084425a00fb94ea [diff] |
Release 8.0.0-pre.20240701.1 (2024-07-12) Baseline: 3f93d377d036d773fd505a18e084425a00fb94ea Important changes: - Experimental support for path mapping `CppCompile` actions can be enabled via `--modify_execution_info=CppCompile=+supports-path-mapping`. This release contains contributions from many people at Google, as well as detailyang, Fabian Meumertzheim, Greg Roodt, hvd, Jason Schroeder, Laurent Le Brun, Simon Mavi Stewart, Xdng Yng.
{Fast, Correct} - Choose two
Build and test software of any size, quickly and reliably.
Speed up your builds and tests: Bazel rebuilds only what is necessary. With advanced local and distributed caching, optimized dependency analysis and parallel execution, you get fast and incremental builds.
One tool, multiple languages: Build and test Java, C++, Android, iOS, Go, and a wide variety of other language platforms. Bazel runs on Windows, macOS, and Linux.
Scalable: Bazel helps you scale your organization, codebase, and continuous integration solution. It handles codebases of any size, in multiple repositories or a huge monorepo.
Extensible to your needs: Easily add support for new languages and platforms with Bazel's familiar extension language. Share and re-use language rules written by the growing Bazel community.
Follow our tutorials:
To report a security issue, please email security@bazel.build with a description of the issue, the steps you took to create the issue, affected versions, and, if known, mitigations for the issue. Our vulnerability management team will respond within 3 working days of your email. If the issue is confirmed as a vulnerability, we will open a Security Advisory. This project follows a 90 day disclosure timeline.
See CONTRIBUTING.md